chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Heart was racing; feeling sick and under the weather; bad body aches; headache; fever of 99.3F; bad chills; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart was racing), MALAISE (feeling sick and under the weather), PAIN (bad body aches), HEADACHE (headache) and PYREXIA (fever of 99.3F) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PALPITATIONS (Heart was racing), MALAISE (feeling sick and under the weather), PAIN (bad body aches), HEADACHE (headache), PYREXIA (fever of 99.3F) and CHILLS (bad chills). On 05-Mar-2021, PALPITATIONS (Heart was racing), MALAISE (feeling sick and under the weather), PAIN (bad body aches) and PYREXIA (fever of 99.3F) had resolved. At the time of the report, HEADACHE (headache) and CHILLS (bad chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Body temperature: 99.3 f (High) 99.3 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drugs are blood pressure, cholesterol and thyroid medications. Treatment medications are Tylenol.
was not feeling well; Little bit of the fever; Came down with the sniffles; This is a spontaneous report from a contactable consumer (patient's husband). This is the second case out of two cases in which reporter was reporting for his wife.  A 67-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN5318 and Expiration date was not reported), via an unspecified route of administration, in Deltoid Left, on an unknown date in Jan2021 as a single dose for COVID-19 immunisation. Medical history included ongoing blood pressure abnormal, Migraine and scoliosis (further clarification about scoliosis was unknown). Concomitant medications included regular pain medication because she has got scoliosis, paracetamol (TYLENOL) and ibuprofen (ADVIL), regular blood pressure medication and medications for Migraine only when it was. It was stated that reporter (patient's husband) and patient both received the first doses of the COVID 19 vaccine a little over 3 weeks ago (in Jan2021) and were scheduled to receive the second dose of the vaccine on 12Feb2021. On Wednesday, his wife came down with the sniffles and on Thursday she was not feeling well and had Little bit of the fever; all were on an unspecified date in 2021. So cancelled their second dose appointments and waiting to get another appointment for their second doses through their insurance. Reporter's daughter is a nurse and told them they only have a 4 day window to receive the second dose of the vaccine in regards to safety. They are going to be getting their second doses of vaccine past the 21 days period; It has already been four days after we were supposed to have the shot. No treatment was received for the events. Outcome of events was reported as not recovered.
hyper mobile Ehlers Danlos; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "COVID/tested positive for COVID", start date: Mar2020 (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Single), administration date: Apr2020, for COVID-19 immunization; Bnt162b2 (Dose 2, Single), for COVID-19 immunization; Bnt162b2 (Dose 3, Single), for COVID-19 immunization. The following information was reported: EHLERS-DANLOS SYNDROME (non-serious), outcome "unknown", described as "hyper mobile Ehlers Danlos".  Additional information: It was reported that patient had confirmed hyper mobile Ehlers Danlos. The event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pregnancy test done 4/05/2014. Negative result. Pt Became Pregnant 4/21/2013. Pregnancy test positive & 4/24/2013 Pregnancy test done in OBGYN Positive results.
Headache Cold feeling Dizzy Sore throat Nauseous Injection site red and hot Pain in left arm
Approximately 45 minutes after receiving Influenza vaccine, patient began experiencing dizziness, a generalized itchy feeling and welts on her stomach, chest, and neck.  Approximately 45 minutes after onset of previous symptoms, sh began to feel as if she would pass out (consciousness never lost) and inabliity to catch her breath.  She was transported by ambulance to the hospital. Benadryl and nasal Oxygen  given with little symptom relief.  Epinephrine was then given, Both drugs caused a rapid heart rate.  Symptoms of dizziness, itching and welts eased.  Oxygen saturation levels improved.  Because of her history of cardimyopathy, she was admitted for further testing and observation. Discharge Summary received on 1/12/2005 states chest pain.
still got the flu; Initial information regarding an unsolicited valid social media non-serious case received via consumer/non-hcp on 30-Dec-2022.  This case involves patient of unknown demographics who still got the flu after getting vaccinated with INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor. The patient's past medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date in October 2022, the patient received suspect INFLUENZA VACCINE produced by unknown manufacturer at (unknown: formulation, strength, dose, lot number, route, administration site) for prophylactic vaccination. Lot number and batch number was not provided. Drug expiry date was not reported. Information regarding batch number requested.   On an unknown date in Dec-2022, the patient developed a non-serious still got the flu (influenza) at few months latency following the administration of INFLUENZA VACCINE.  It was reported that "we got our flu shots on Oct, still got the flu this Christmas vacation. Maybe a little less complication, thankfully, but still got it, first time in 10 years." It was unknown if the company suspect product inappropriately used as per local Regulatory authorization.  Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event Influenza.
Reaction was more intense, but of shorter duration than the reaction to the first shot on 4/15/2021  (lot # ER8729)  I experienced weakness, dizziness and remained in bed until 5 PM on Saturday 5/8/2021, the day after the shot. This time, there was no pain, swelling, or redness at the shot location on my right arm.  I experienced a loss of appetite, slight headache and some groin aches through most of the day on Saturday.  I'm feeling much better today, Sunday 5/9/2021.  Side effects from the first shot lasted a full two days
Client advised 5 vaccines recommended, client had not eaten, this RN gave her crackers to eat while drawing up vaccines.  HepA and Flu given first.  Mening, Tdap, and HPV given last, in that order.  Client immediately reported feeling faint after the last vaccine and not being able to see well, pallid color.  RN put cool cloth on her neck and called mom over to support her. Both eyes dilated before slumping in faint in chair. RN retrieved ice pack, called in another RN for water.  Client revived in less than a minute, mom and RN supported her to lying position. After 5 min she was sitting, sipping water, after 10 from incident, she was talking and stating she was feeling better.  Stayed in office 15 more before mom walked her out to the car. Face: color returned, vision fine, client stated feeling better, still sipping water and asking to stay out of school the rest of the day, making mom state that she must be fully recovered.
Narrative: COVID infection after completion of COVID vaccine series: 02/04/2021 COVID vaccine dose #1 02/25/2021 COVID vaccine dose #2 07/09/2021 Pt presented to ED c/o 5-day hx of SOB, fever and chills, and non-productive cough. Stated that other family members had symptoms and recent dx of COVID (close contact exposure). 07/09/2021 positive per nasopharyngeal swab 07/09/2021 Pt administered IV azithromycin and Decadron and placed on 2L NC. Attempted to be discharged, but experienced desaturation on room air. 07/09/2021 Pt admitted to inpatient service. 07/10/2021 Pharmacy approved use of remdesivir as pt met criteria. (Day 1 of 5-day course) 07/11/2021 MD attending reported pt improving symptomatically. Day 2 of remdesivir therapy. Continuation of Decadron. 07/12/2021 MD attending reported pt improving. Day 3 or remdesivir therapy. Continuation of Decadron. 07/13/2021 MD attending reported pt continued feeling better and had been off O2 support for some time in the morning but back on 2L NC. Discussed possible discharge after completion of remdesivir course. Day 4 of remdesivir therapy. Continuation of Decadron.
PAIN AND WEAKNESS OF RIGHT ARM.  HURT FOR SEVERAL WEEKS.  TOOK IBUPROPHEN.  TOLD DOCTOR AT NEXT VISIT. PAIN SUBSIDED, BUT CONTINUOUS. IN FEBRUARY, ROTATOR CUFF TORE AFTER SIMPLE MOVEMENT OF ARM. XRAYS AND MRI - YEAR LATER STILL HURTS.
Bilateral tinnitus 5 days after vaccine administration, imbalance and vertigo started after in combination with hearing loss. Patient stated quality of life is dramatically affected since. It is still unresolved and patient has appointment for check up.
Mother notified agency 07/15/2003 that son has had fever 07/09 thru 07/15 spikes at 104.5, this AM (07/15/2003) no rash, no vomiting, diarrhea.  Denies other symptoms.  Could not specify fever.
Patient stated that she had itchiness and redness at the injection site for about 2 weeks. She took Tylenol for the pain and it mostly went away.
This spontaneous report as received from a nurse refers to an unknown number of patients of unknown age and gender. On 23-JUN-2013, patients were vaccinated with PROQUAD (dose, route and lot number were not reported). Concomitant medications were not reported. Nurse stated that an unspecified number of patients may had received PROQUAD (Merck) (dose in series unspecified) that was stored improperly at 6.5F for 30 minutes cumulatively (10 minutes each excursion). Nurse stated vaccines were administered on 23-JUN-2014. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
patient was administrated by error Kinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-month-old female patient who received DTPa-IPV (Kinrix) (batch number 3DZ45, expiry date 15th January 2022) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 30th March 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 30th March 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The nurse reported that a 11 months old patient was administered Kinrix by error, which led to inappropriate age at vaccine administration. No adverse event was reported. The reporter consented to follow up.
Incident Details: Per Dr.'s email sent out on 9/1/22-"the monovalent mRNA COVID-19 vaccines are not authorized as booster doses for individuals 12 years of age and older. Any patients that are currently scheduled to receive a booster should wait until we have the bivalent booster on hand." The patient, was seen in office on 9/2/22 and received a booster dose of the monovalent mRNA COVID-19 vaccine (pfizer) by nurse in error as patients are now only supposed to receive the bivalent booster per Dr.'s email. Pt was due for booster at the time they received it, however the bivlalent booster was not yet stocked at facility. Possible Cause: Possible cause of the incident is that an email was sent out regarding the discontinuation  of monovalent covid boosters until facility receives the bivalent booster doses. This was overlooked by management and staff, as previous changes to clinic processes is usually discussed in a meeting. Also ?monovalent? and ?bivalent? are new terms that have not previously been used when discussing booster vaccines.  Corrective Action: Corrective action included notifying staff and providers of the recent change regarding COVID vaccines and were notified to stop giving COVID booster doses until the Clinic receives the bivalent vaccines. Staff and providers were notified via email, skype, and verbally. Incident reported to VAERS. Recommendation: I would recommend holding a meeting to notify Leads/Supervisors/Managers of any changes regarding COVID vaccine administration, rather than sending out an email that may not be read by all staff. If an email is needed to be sent, I recommend making it clear that a process is being changed.
31OCT watery diarrhea @ 8hr;1NOV muscle aches, flu-like sx;2NOV cough, stuffy nose; no fever;
experienced itchiness around her legs; her arm felt heavy; This is a spontaneous report from a contactable consumer or other non hcp. A 40-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection), Dose 1 via an unspecified route of administration, administered in Arm Right on 09Feb2021 16:00 (Batch/Lot Number: EM9809) as DOSE 1, SINGLE for Covid-19 immunization. Medical history included allergy, heart burn, she is allergic to Shellfish, she is allergic to eggs, she is allergic to nuts, she is allergic to Penicillin from an unknown date and unknown if ongoing. She provided relevant family history as heart issues and diabetes. Concomitant medication included Escitalopram oxalate (LEXAPRO); Bupropion hydrochloride (WELLBUTRIN) taken for unspecified indication; Famotidine (PEPCID [FAMOTIDINE]); Omeprazole (PRILOSEC [OMEPRAZOLE]) taken for Dyspepsia. The patient experienced Itchiness around her legs on 09Feb2021 17:15, Her arm felt heavy on 09Feb2021 16:45. Patient took Benadryl for therapeutic measures as a result of experienced itchiness around her legs, her arm felt heavy. It was reported that, she had her first dose of the covid vaccine at 4PM yesterday then at 5:15PM or 5:30PM she started feeling itchiness around the leg and felt a heavy arm. She took Benadryl and felt better. The product is the Covid 19 Vaccine. Patient clarified that her First Dose was on 09Feb2021 4PM, then at 5:15PM she started to notice the itchiness around both legs. The heaviness was in the Right Arm and started around 4:45PM, she adds that she feels the heaviness in the same arm that she received the injection. She took the Benadryl around 6:15PM. Patient stated that the vaccine Lot was on a sticker posted on the card. Her scheduled second dose is on 02Mar2021. Patient stated that she has had no positive covid test or positive antibody test prior to the vaccine. She has had no other vaccines on the same day as her covid vaccine and no vaccines in the last 4 weeks. She did not have to have any visit to the ER or physician office. Patient stated that she was just a little afraid to get the second dose and wants to know if it was okay. Outcome of the event experienced Itchiness around her legs was recovered on 09Feb2021, and not recovered from her arm felt heavy.
Post concussive symptoms; headache; trouble multi-tasking; difficulty remembering sequence in routinetasks.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm right on 28Mar2021(at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included concussion and post-concussion syndrome. Concomitant medications included minerals nos, vitamins nos (ONE A DAY VITAMIN) from unknown date for unknown indication. The patient was having allergy to hydrocodone. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration on right arm on 07Mar2021, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 29Mar2021 the patient experienced post concussive symptoms including a headache, trouble multi-tasking and difficulty remembering sequence in routine tasks.  The patient reported that she had experienced a concussion about 18Feb2020. Post concussive symptoms continued for about 6 months after. After the second vaccination, she experienced similar post concussive symptoms including a headache, trouble multi-tasking, difficulty remembering sequence in routine tasks. The clinical outcome of the events post concussive symptoms, headache, trouble multi-tasking and difficulty remembering sequence in routine were not recovered.  No follow-up attempts are needed. No further information is expected.
Day following second dose (8/17/2021) I was sore all over.  That resolved after two days.  However, I now have significant pain in my right buttock that is so bad I have a hard time walking without a cane.  The buttock pain feels a lot like a pulled muscle.   As of 8/20/21 noon I have not noticed any improvement in my right buttock.  I am also noticing tingling in my hands which started today and prompted me to report adverse event.
Swollen L axillary lymph nodes 24 hours after receiving vaccine in L deltoid.; This is a spontaneous report from a non-contactable healthcare professional, reporting for herself. A 20-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were unknown), via an unspecified route of administration at the left deltoid on 23Jan2021 10:00 at a single dose for COVID-19 immunization. Vaccination was done in a Pharmacy/drug store. Medical history included allergies: penicillin (PCN) from an unknown date and unknown if ongoing. The patient was not pregnant. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 at the left arm on 02Jan2021 11:00 for COVID-19 immunization. The patient experienced swollen left axillary lymph nodes on 24Jan2021 07:00 (reported as 24 hours after receiving vaccine in left deltoid). No treatment was received. It was unknown if the patient had COVID prior vaccination. The patient had not had COVID tested post vaccination. There was no other vaccine in four weeks. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt experienced flu like symptoms, nausea, loss of appetite, muscle aches, lethargy, fever blisters on face.
This case was reported by a consumer and described the occurrence of eye swelling in a 54-year-old female patient who received Influenza vaccine Quadrivalent, GAVISCON Extra Strength Liquid oral liquid (batch number 7C12C1, expiry date 28th February 2019) for heartburn. Previously administered products included flu shot with an associated reaction of no adverse event. On 3rd October 2017, the patient started GAVISCON Extra Strength Liquid at an unknown dose and frequency. On 3rd October 2017, less than an hour after starting GAVISCON Extra Strength Liquid, the patient experienced eye swelling, swollen tongue and tingling mouth. GAVISCON Extra Strength Liquid was discontinued on 3rd October 2017 (Dechallenge was unknown). On an unknown date, the outcome of the eye swelling, swollen tongue and tingling mouth were unknown. It was unknown if the reporter considered the eye swelling, swollen tongue and tingling mouth to be related to GAVISCON Extra Strength Liquid. Additional details: Adverse event information was received on 3 October 2017. Consumer reported that she used GAVISCON Extra Strength on and off for the last 6 months. She had a Flu shot one week ago and was taking other medications. She took GAVISCON today at four passes forty five minutes in morning and around five to five passes fifteen minutes in morning she started having a tingling feeling in mouth and tongue started to swell as well as swelling around the eyes. Consumer reported that this never happened before over the years using GAVISCON. She stopped taking immediately. The concomitant medication included other medications. Upon receiving clarification reply the following error correction was done on 8th December 2017: In September 2017, the patient received a flu shot (Influenza vaccine Quadrivalent). On 3rd October 2017, less than a month after vaccination the patient experienced tingling mouth and tongue as well as swelling around the eyes. It was unknown if the reporter considered all these events to be related to Influenza vaccine Quadrivalent (flu shot).
3RD DOSE MODERNA COVID VACCINE GIVEN 8/19/21, #088D; pt had a positive  COVID test recorded on 1/20/22 by local facility; pt passed away at home - no medical records able to be obtained 3/16/22 (after death on 3/15/22) local facility reported a positive COVID test
Wrong dose administered for 12 year old. Patient received Pfizer COVID vaccine 0.2mL instead of 30mcg/0.3mL on 12/1/21 1553. No adverse effects reported.
Felt like he had flu like symptoms that felt like when he had covid; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like he had flu like symptoms that felt like when he had covid) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (He had COVID in November.).    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like he had flu like symptoms that felt like when he had covid). On 26-Feb-2021, INFLUENZA LIKE ILLNESS (Felt like he had flu like symptoms that felt like when he had covid) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided.  No treatment information was reported.
Patient came in to get booster shot (3rd dose). He passed-out right when he opened the car door to go home. His dad called 911 and patient admitted to hospital. His dad came back to pharmacy to report incident at 12:45 pm. Around 4 pm, pharmacy gave him a callback to check on him. His mom said he was released from hospital and at home doing ok. The hospital said the shot might lower his blood pressure and that is why he passed-out (per mom). They will update us if there is anything further to happen.